Oncology & Cancer

Researchers define unique group of high-risk lymphoma patients

The goal for many cancer patients is to reach the five-year, disease-free mark, but new research from UR Medicine's Wilmot Cancer Institute suggests that two years might be a more practical survival goal for people with follicular ...

Oncology & Cancer

Scientists trace genomic evolution of high-risk leukemia

By genomic sequencing of leukemia cells from relapsed patients at different stages, scientists have discovered key details of how acute lymphoblastic leukemia (ALL) cells mutate to survive chemotherapy. These mutations enable ...

Oncology & Cancer

Discovery of the genetic fingerprint of aggressive colon tumors

About 40-50% of all colorectal patients relapse in the form of metastasis. In the last three years, several molecular classifications have been proposed to identify colorectal cancer patients at risk of relapse. Today in ...

Pediatrics

New approach to childhood malnutrition may reduce relapses, deaths

Children treated for moderate acute malnutrition—a condition suffered by an estimated 35 million children worldwide—experience a disturbingly high rate of relapse and even death in the year following treatment and recovery.

Medications

Lurasidone in schizophrenia: Added benefit is not proven

The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment ...

Diseases, Conditions, Syndromes

A new way of improving tuberculosis treatment rejected

Tuberculosis kills 1.5 million people across the world every year. The existing treatment is effective but long. Many patients abandon it before completion, increasing the risk of a relapse and favouring the emergence of ...

page 16 from 30